Vita Life Sciences Income Statement

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	93.27	79.51	73.43	66.89	57.1
Revenue Growth (YoY)	17.31%	8.28%	9.78%	17.14%	22.85%
Cost of Revenue	36.23	32.26	31.05	27.15	22.29
Gross Profit	57.04	47.24	42.38	39.74	34.81
Selling, General & Admin	42.41	35.19	30.17	28.7	23.54
Other Operating Expenses	0.59	0.4	0.34	0.31	0.26
Operating Expenses	43	35.59	30.51	29.01	23.79
Operating Income	14.04	11.66	11.88	10.73	11.02
Interest Expense	-0.11	-0.05	-0.06	-	-0.06
Interest & Investment Income	0.99	1.04	0.56	0.14	0.14
Currency Exchange Gain (Loss)	-0.29	0.07	-0.21	-0.12	0.01
Other Non Operating Income (Expenses)	-0.22	-0.08	-0.05	-0	0.11
EBT Excluding Unusual Items	14.4	12.64	12.12	10.75	11.21
Gain (Loss) on Sale of Assets	-	-	-	-	-0
Asset Writedown	0.03	-	0.34	-0.01	-0.01
Pretax Income	14.43	12.64	12.45	10.74	11.2
Income Tax Expense	4	3.86	3.37	3.4	2.95
Earnings From Continuing Operations	10.43	8.78	9.08	7.34	8.25
Minority Interest in Earnings	0.01	0.01	0	-0.26	0.05
Net Income	10.44	8.78	9.08	7.08	8.29
Net Income to Common	10.44	8.78	9.08	7.08	8.29
Net Income Growth	18.80%	-3.26%	28.18%	-14.57%	36.07%
Shares Outstanding (Basic)	56	56	54	53	53
Shares Outstanding (Diluted)	57	56	55	54	53
Shares Change (YoY)	2.27%	1.70%	1.30%	1.64%	0.97%
EPS (Basic)	0.19	0.16	0.17	0.13	0.16
EPS (Diluted)	0.18	0.16	0.17	0.13	0.16
EPS Growth	16.21%	-4.88%	26.52%	-15.95%	34.80%
Free Cash Flow	15.86	5.96	12.32	2.64	5.73
Free Cash Flow Per Share	0.28	0.11	0.23	0.05	0.11
Dividend Per Share	0.140	0.100	0.090	0.060	0.058
Dividend Growth	40.00%	11.11%	50.00%	4.35%	35.29%
Gross Margin	61.15%	59.42%	57.72%	59.41%	60.96%
Operating Margin	15.05%	14.66%	16.17%	16.04%	19.29%
Profit Margin	11.19%	11.05%	12.37%	10.59%	14.52%
Free Cash Flow Margin	17.00%	7.49%	16.78%	3.94%	10.04%
EBITDA	14.52	12.01	12.12	10.98	11.25
EBITDA Margin	15.57%	15.11%	16.51%	16.42%	19.71%
D&A For EBITDA	0.49	0.36	0.25	0.25	0.24
EBIT	14.04	11.66	11.88	10.73	11.02
EBIT Margin	15.05%	14.66%	16.17%	16.04%	19.29%
Effective Tax Rate	27.75%	30.55%	27.09%	31.64%	26.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.